Ketamine Terminated Phase 2 Trials for Malignancies / Depression / Anxiety Supportive Care

IndicationsStatusPurposePhase
TerminatedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT01680172Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer